Qiagen NV has terminated its agreement to be acquired by Thermo Fisher Scientific after shareholders rejected an amended offer price.
On 16 July, Thermo Fisher Scientific and Qiagen announced an amendment to the original $11.5bn buyout announced in March. Thermo...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?